Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 16.6% CAGR in terms of revenue, the global market size will reach $ 6505.6 million by 2025, from $ 3519.9 million in 2019. In particular, this report presents the global revenue market share of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Irritable Bowel Syndrome (IBS) market by type, application, key companies and key regions.
This study considers the Irritable Bowel Syndrome (IBS) value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
IBS-D Drug
IBS-C Drug
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Women
Men
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Bausch Health
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Takeda
IM HealthScience
Sebela Pharmaceuticals
Astellas Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Irritable Bowel Syndrome (IBS) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
Focuses on the key global Irritable Bowel Syndrome (IBS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size 2015-2025
2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-D Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (2015-2020)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application (2015-2020)
3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Market Size by Players (2018-2020)
3.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players (2018-2020)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) Market Size by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Market Size Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Market Size Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Market Size Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth
5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Countries
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Regions
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Irritable Bowel Syndrome (IBS) Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2021-2025)
10.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
10.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
10.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application
11 Key Players Analysis
11.1 Allergan
11.1.1 Company Details
11.1.2 Irritable Bowel Syndrome (IBS) Product Offered
11.1.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Allergan News
11.2 Bausch Health
11.2.1 Company Details
11.2.2 Irritable Bowel Syndrome (IBS) Product Offered
11.2.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Bausch Health News
11.3 Sucampo Pharmaceuticals
11.3.1 Company Details
11.3.2 Irritable Bowel Syndrome (IBS) Product Offered
11.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Sucampo Pharmaceuticals News
11.4 McNeil Consumer Healthcare
11.4.1 Company Details
11.4.2 Irritable Bowel Syndrome (IBS) Product Offered
11.4.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 McNeil Consumer Healthcare News
11.5 Takeda
11.5.1 Company Details
11.5.2 Irritable Bowel Syndrome (IBS) Product Offered
11.5.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Takeda News
11.6 IM HealthScience
11.6.1 Company Details
11.6.2 Irritable Bowel Syndrome (IBS) Product Offered
11.6.3 IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 IM HealthScience News
11.7 Sebela Pharmaceuticals
11.7.1 Company Details
11.7.2 Irritable Bowel Syndrome (IBS) Product Offered
11.7.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Sebela Pharmaceuticals News
11.8 Astellas Pharmaceuticals
11.8.1 Company Details
11.8.2 Irritable Bowel Syndrome (IBS) Product Offered
11.8.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Astellas Pharmaceuticals News
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Irritable Bowel Syndrome (IBS) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of IBS-D Drug
Table 5. Major Players of IBS-C Drug
Table 6. Major Players of Other
Table 7. Irritable Bowel Syndrome (IBS) Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 9. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2018-2020)
Table 13. Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions 2015-2020
Table 19. Americas Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 21. Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 23. Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 25. APAC Irritable Bowel Syndrome (IBS) Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions (2015-2020)
Table 27. APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 29. APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 31. Europe Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Irritable Bowel Syndrome (IBS)
Table 44. Key Application and Potential Industries of Irritable Bowel Syndrome (IBS)
Table 45. Key Challenges of Irritable Bowel Syndrome (IBS)
Table 46. Key Trends of Irritable Bowel Syndrome (IBS)
Table 47. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Regions
Table 49. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Application (2021-2025)
Table 53. Allergan Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 54. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 55. Allergan Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 56. Allergan Main Business
Table 57. Allergan Latest Developments
Table 58. Bausch Health Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 59. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 60. Bausch Health Main Business
Table 61. Bausch Health Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 62. Bausch Health Latest Developments
Table 63. Sucampo Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 64. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 65. Sucampo Pharmaceuticals Main Business
Table 66. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 67. Sucampo Pharmaceuticals Latest Developments
Table 68. McNeil Consumer Healthcare Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 69. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product Offered
Table 70. McNeil Consumer Healthcare Main Business
Table 71. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 72. McNeil Consumer Healthcare Latest Developments
Table 73. Takeda Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 74. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 75. Takeda Main Business
Table 76. Takeda Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 77. Takeda Latest Developments
Table 78. IM HealthScience Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 79. IM HealthScience Irritable Bowel Syndrome (IBS) Product Offered
Table 80. IM HealthScience Main Business
Table 81. IM HealthScience Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 82. IM HealthScience Latest Developments
Table 83. Sebela Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 84. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 85. Sebela Pharmaceuticals Main Business
Table 86. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 87. Sebela Pharmaceuticals Latest Developments
Table 88. Astellas Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 89. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 90. Astellas Pharmaceuticals Main Business
Table 91. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 92. Astellas Pharmaceuticals Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Figure 5. Global IBS-D Drug Market Size Growth Rate
Figure 6. Global IBS-C Drug Market Size Growth Rate
Figure 7. Global Other Market Size Growth Rate
Figure 8. Irritable Bowel Syndrome (IBS) in Women
Figure 9. Global Irritable Bowel Syndrome (IBS) Market: Women (2015-2020) ($ Millions)
Figure 10. Irritable Bowel Syndrome (IBS) in Men
Figure 11. Global Irritable Bowel Syndrome (IBS) Market: Men (2015-2020) ($ Millions)
Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions 2015-2020
Figure 14. Americas Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 15. APAC Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 16. Europe Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 17. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 18. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 19. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 21. United States Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 22. Canada Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 23. Mexico Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 24. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions in 2019
Figure 25. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 27. China Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 28. Japan Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 29. Korea Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 31. India Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 32. Australia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 33. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 35. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 36. Germany Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 37. France Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 38. UK Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 39. Italy Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 40. Russia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Spain Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 45. Egypt Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 46. South Africa Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 47. Israel Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 48. Turkey Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 49. GCC Countries Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Global Irritable Bowel Syndrome (IBS) arket Size Forecast (2021-2025) ($ Millions)
Figure 51. Americas Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 52. APAC Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 53. Europe Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 55. United States Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 56. Canada Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 57. Mexico Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 58. Brazil Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 59. China Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 60. Japan Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 61. Korea Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 63. India Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 64. Australia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 67. UK Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 68. Italy Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 69. Russia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 70. Spain Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 71. Egypt Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 72. South Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 73. Israel Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 74. Turkey Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 75. GCC Countries Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets